PlainPharmaWatch

CMS Open Payments · Tool

Fusion Orthopedics USA, LLC vs Xtant Medical Inc

Side-by-side comparison of CMS Open Payments data for Program Year 2024. Select different companies below to start a new comparison.

A larger reported total is not "better" or "worse", it is a neutral fact about disclosure volume; a reported payment documents a financial relationship, not evidence of wrongdoing.

Compare Different Companies

vs

Relationship comparison

Which recorded payment profile is more concentrated?

Xtant Medical Inc has the more concentrated recorded General Payments recipient profile in Program Year 2024: its recipient-distribution HHI is 666, versus 458 for the other company. Its single largest recorded recipient represents 16.7% of that company's General Payments recipient total.

HHI summarizes how payments are distributed across recorded recipients: higher means a less evenly distributed recipient pattern. This is a description of CMS-reported General Payments only, not a finding about conduct, prescribing, quality, or wrongdoing. Read it with the recipient count and underlying records below.

Fusion Orthopedics USA, LLC
HHI 458 · top recipient 13.1%
Ranked #1,320 of 1,838 companies by HHI
Xtant Medical Inc
HHI 666 · top recipient 16.7%
Ranked #1,189 of 1,838 companies by HHI

Payment Overview

Total Payments
$655.1K
% of Industry
0.0%
Transactions
780
Avg per Transaction
$839.81
Recipients
780
Avg per Recipient
$839.81
Payment Types
4
Top Payment Type
Consulting Fee
Company B

Xtant Medical Inc

Total Payments
$659.3K
% of Industry
0.0%
Transactions
454
Avg per Transaction
$1.5K
Recipients
454
Avg per Recipient
$1.5K
Payment Types
4
Top Payment Type
Consulting Fee

Highlighted values indicate the higher figure for each metric.

Total payments compared

Fusion Orthopedics USA, LLC vs Xtant Medical Inc - total reported payments in CMS Open Payments PY2024

Xtant Medical Inc$659.3KFusion Orthopedics USA, LLC$655.1K

General Payment Types Breakdown

Category shares use each company's General Payments total, not the all-tracks (General + Research + Ownership) hero figure.

Fusion Orthopedics USA, LLC

Consulting Fee $471.0K

71.9%

Royalty or License $107.2K

16.4%

Travel and Lodging $40.0K

6.1%

Food and Beverage $37.0K

5.6%

Xtant Medical Inc

Consulting Fee $476.6K

72.3%

Royalty or License $123.4K

18.7%

Travel and Lodging $36.4K

5.5%

Food and Beverage $22.8K

3.5%

Top 5 General-Payment Recipients

This list uses CMS detailed General Payments records only; it excludes research and ownership/investment records, so it does not equal the all-category totals above. A reported payment documents a financial relationship, not evidence of wrongdoing; a higher total reflects reporting volume, not conduct. Verify directly at openpaymentsdata.cms.gov.

Fusion Orthopedics USA, LLC

  1. 1

    DAVID CALDARELLA

    $85,863.18 · 19 txns

  2. 2

    BEN WEHRLI

    $84,062.22 · 20 txns

  3. 3

    JAMES COTTOM

    $25,000.00 · 1 txns

  4. 4

    PAUL BISHOP

    $24,284.81 · 8 txns

  5. 5

    ADAM GOUGH

    $24,000.00 · 4 txns

Xtant Medical Inc

  1. 1

    DUKE OSCAR KASPRISIN

    $109,869.28 · 14 txns

  2. 2

    KENNETH CONGER

    $77,949.46 · 13 txns

  3. 3

    SALLY FATHI ALRABAA

    $57,250.00 · 4 txns

  4. 4

    PETER HERBERT CHEROUNY

    $51,254.76 · 13 txns

  5. 5

    DAVID JOHN YEH

    $33,507.27 · 31 txns

Summary Comparison

Metric Fusion Orthopedics USA, LLC Xtant Medical Inc
Total Payments $655.1K $659.3K
% of Industry Total 0.0% 0.0%
Transaction Count 780 454
Avg per Transaction $839.81 $1.5K
Recipient Count 780 454
Avg per Recipient $839.81 $1.5K
Payment Type Count 4 4
Top Payment Type Consulting Fee Consulting Fee

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. All companies in the CMS Open Payments company corpus are available in the selector. Browse all companies →

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.